Compound ID | 3261

Update compound information

Pradofloxacin

Class: Fluoroquinolone

Agent Type: Synthetic; Small molecule; Direct acting;
Spectrum of activity: Gram-positive & Gram-negative
Mechanism of action: DNA synthesis inhibitor. Bacterial topoisomerase inhibitor
Target Pathogen: Broad-spectrum activity including anaerobic bacteria and mycoplasmas
Description: Synthetic compound; an 8-cyanofluoroquinolone for veterinary use
Year first mentioned: 2005
Highest developmental phase: Approved for veterinary use
Development status: Experimental
Chemical structure(s):
Click here for structure editor
Molecular weight: 396.42
Iso. SMILES: C1C[C@H]2CN(C[C@H]2NC1)C3=C(C=C4C(=C3C#N)N(C=C(C4=O)C(=O)O)C5CC5)F
InChI Key: LZLXHGFNOWILIY-APPDUMDISA-N
Can. SMILES: C1C[C@H]2CN(C[C@H]2NC1)C3=C(C#N)C4=C(C=C3F)C(=O)C(=CN4C5CC5)C(=O)O
InChI: InChI=1S/C21H21FN4O3/c22-16-6-13-18(26(12-3-4-12)9-15(20(13)27)21(28)29)14(7-23)19(16)25-8-11-2-1-5-24-17(11)10-25/h6,9,11-12,17,24H,1-5,8,10H2,(H,28,29)/t11-,17+/m0/s1
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/9802884
Guide to Pharmacology: pradofloxacin
Citation: https://www.sciencedirect.com/science/article/abs/pii/S1090023314002640?via%3Dihub

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.